निफेडिपिन के इंटरैक्शन

हम जिन FDA लेबल और फैक्ट शीट को इंडेक्स करते हैं, उनमें निफेडिपिन (Procardia, Adalat; डाइहाइड्रोपाइरिडीन कैल्शियम चैनल ब्लॉकर) के 424 इंटरैक्शन दर्ज हैं: 52 गंभीर, 262 मध्यम, 94 मामूली, और 16 ऐसे जिनमें लेबल बताता है कि कोई महत्वपूर्ण इंटरैक्शन नहीं है। नीचे की हर प्रविष्टि उस वाक्य को उद्धृत करती है जिस पर वह आधारित है। दवा का यह पेज एक शुरुआती बिंदु है, आपकी स्थिति के लिए कोई फ़ैसला नहीं।

लेबल से लिए गए इंटरैक्शन

गंभीर इंटरैक्शन (52)

  • आर्मोडाफिनिलCNS स्टिमुलेंटगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • इट्राकोनाज़ोलएज़ोल एंटीफंगलगंभीर

    Calcium Channel Blockers Felodipine Nisoldipine Contraindicated during and 2 weeks after TOLSURA treatment. (इट्राकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

  • एट्राविरिनएंटीरेट्रोवायरलगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एप्टिफिबाटाइडएंटीप्लेटलेट दवागंभीर

    …of active abnormal bleeding within the previous 30 days Severe hypertension (systolic blood pressure >200 mm Hg or diastolic blood pressure >110 mm Hg) not adequately controlled on antihypertensive therapy Major surgery within the preceding 6 weeks History of stroke within 30 days or any history of hemorrhagic stroke Current or planned administration of another… (एप्टिफिबाटाइड लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • एप्रेपिटेंटCYP3A4 इनहिबिटरगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एफाविरेंज़एंटीरेट्रोवायरलगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एस्मोलोलबीटा ब्लॉकरगंभीर

    IV administration of cardiodepressant calcium-channel antagonists (e.g., verapamil) and BREVIBLOC in close proximity (i.e., while cardiac effects from the other are still present); fatal cardiac arrests have occurred in patients receiving BREVIBLOC and intravenous verapamil. (एस्मोलोल लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • एस्लिकार्बाज़ेपिनएंटीकन्वल्सेंट (दौरे की दवा)गंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ऑक्सकार्बाज़ेपिनएंटीकन्वल्सेंट (दौरे की दवा)गंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • कार्बामाज़ेपिनएंटीकन्वल्सेंट (दौरे की दवा)गंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • • Calcium Channel Blockers: Avoid concomitant use with Calcium Chloride Injection. (कैल्शियम क्लोराइड लेबल, दवाओं के इंटरैक्शन)

  • कैल्सिट्रिओलविटामिन D एनालॉगगंभीर

    Calcium Supplements Uncontrolled intake of additional calcium-containing preparations should be avoided (see PRECAUTIONS: General ). (कैल्सिट्रिओल लेबल, दवाओं के इंटरैक्शन)

  • क्लैड्रिबिनएंटीमेटाबोलाइटगंभीर

    Prevention or Management Avoid co-administration of potent ENT1, CNT3, or BCRP transporter inhibitors (e.g., ritonavir, eltrombopag, curcumin, cyclosporine, dilazep, nifedipine, nimodipine, cilostazol, sulindac, dipyridamole, or reserpine) during the 4 to 5 day MAVENCLAD treatment cycles. (क्लैड्रिबिन लेबल, दवाओं के इंटरैक्शन)

  • क्लैरिथ्रोमाइसिनमैक्रोलाइड एंटीबायोटिकगंभीर

    …with colchicine; markedly increased transaminases with lomitapide; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; hypoglycemia and cardiac arrhythmias (e.g., torsades de pointes) with disopyramide; and hypotension and acute kidney injury with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem, nifedipine). (क्लैरिथ्रोमाइसिन लेबल, चेतावनियां और सावधानियां)

  • क्लोज़ापिनएंटीसाइकोटिकगंभीर

    Use CLOZARIL cautiously in patients with cardiovascular or cerebrovascular disease or conditions predisposing to hypotension (e.g., dehydration, use of antihypertensive medications) [see Dosage and Administration ( 2.2 , 2.6 ), Warnings and Precautions ( 5.2 )]. (क्लोज़ापिन लेबल, बॉक्स्ड चेतावनी)

  • क्लोबाज़ामबेंज़ोडायज़ेपिनगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ग्रिसियोफुल्विनएंटीफंगलगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ग्रेपफ्रूट (चकोतरा)खाद्य और पेय पदार्थगंभीर

    Grapefruit juice should be avoided by patients on nifedipine. (निफेडिपिन लेबल, सावधानियां)

  • टैडालाफिलPDE5 इनहिबिटरगंभीर

    …coadministration of an alpha-blocker and CIALIS for the treatment of BPH has not been adequately studied, and due to the potential vasodilatory effects of combined use resulting in blood pressure lowering, the combination of CIALIS and alpha-blockers is not recommended for the treatment of BPH. [see Dosage and Administration ( 2.7 ), Drug Interactions ( 7.1 ),… (टैडालाफिल लेबल, चेतावनियां और सावधानियां)

  • टोपिरामेटएंटीकन्वल्सेंट (दौरे की दवा)गंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • डिगॉक्सिनडिजिटेलिस ग्लाइकोसाइडगंभीर

    Since there have been isolated reports of patients with elevated digoxin levels, and there is a possible interaction between digoxin and nifedipine extended-release tablet, it is recommended that digoxin levels be monitored when initiating, adjusting and discontinuing nifedipine extended-release tablet to avoid possible over- or under-digitalization. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • डेक्सामेथासोनकॉर्टिकोस्टेरॉइडगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • डेफेरासिरोक्सआयरन सप्लीमेंटगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • डैंट्रोलीनमसल रिलैक्सेंटगंभीर

    The concomitant use of RYANODEX and calcium channel blockers is not recommended during the treatment of malignant hyperthermia. (डैंट्रोलीन लेबल, दवाओं के इंटरैक्शन)

  • नियोमाइसिनएमिनोग्लाइकोसाइडगंभीर

    If blockage occurs, calcium salts may reverse these phenomena but mechanical respiratory assistance may be necessary. (नियोमाइसिन लेबल, बॉक्स्ड चेतावनी)

  • नेविरापिनएंटीरेट्रोवायरलगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • नैफसिलिनपेनिसिलिन एंटीबायोटिकगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • प्रिमिडोनएंटीकन्वल्सेंट (दौरे की दवा)गंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • फेंटरमिन और टोपिरामेटCNS स्टिमुलेंटगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • फेनिटोइनएंटीकन्वल्सेंट (दौरे की दवा)गंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • फेनोबार्बिटोनबार्बिट्यूरेटगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • फॉस्फेनिटोइनएंटीकन्वल्सेंट (दौरे की दवा)गंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • बीटाक्सोलोलबीटा ब्लॉकरगंभीर

    Literature reports suggest that oral calcium antagonists may be used in combination with beta-adrenergic blocking agents when heart function is normal, but should be avoided in patients with impaired cardiac function. (बीटाक्सोलोल लेबल, दवाओं के इंटरैक्शन)

  • बोसेंटनCYP3A4 इंड्यूसरगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • माइटोटेनCYP3A4 इंड्यूसरगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • मिटापिवैटCYP3A4 इंड्यूसरगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • मिनोक्सिडिलवैसोडाइलेटरगंभीर

    Minoxidil should be reserved for hypertensive patients who do not respond adequately to maximum therapeutic doses of a diuretic and two other antihypertensive agents. (मिनोक्सिडिल लेबल, बॉक्स्ड चेतावनी)

  • मेटोलाज़ोनथायज़ाइड डाइयूरेटिकगंभीर

    Other Antihypertensive Drugs When metolazone tablets, USP, are used with other antihypertensive drugs, particular care must be taken to avoid excessive reduction of blood pressure, especially during initial therapy. (मेटोलाज़ोन लेबल, चेतावनियां)

  • मोडाफिनिलCNS स्टिमुलेंटगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • रिटोनाविरएंटीरेट्रोवायरलगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • रिफापेंटिनएंटीबायोटिकगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • रिफाब्यूटिनएंटीबायोटिकगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • रिफैम्पिसिनएंटीबायोटिकगंभीर

    CONTRAINDICATIONS Concomitant administration with strong P450 inducers, such as rifampin, are contraindicated since the efficacy of nifedipine tablets could be significantly reduced. (निफेडिपिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • लेबेटालोलबीटा ब्लॉकरगंभीर

    IV administration of non-dihydropyridine calcium-channel antagonists (e.g., verapamil) Hypersensitivity reactions, including anaphylaxis, to labetalol Bronchial asthma ( 4 ) (लेबेटालोल लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • लोपिनाविर और रिटोनाविरएंटीरेट्रोवायरलगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • लोरलाटिनिबCYP3A4 इंड्यूसरगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • साइक्लोस्पोरिनइम्यूनोसप्रेसेंटगंभीर

    The concomitant use of nifedipine should be avoided in patients in whom gingival hyperplasia develops as a side effect of cyclosporine. (साइक्लोस्पोरिन लेबल, दवाओं के इंटरैक्शन)

  • सुज़ेट्रिजिनCYP3A4 इंड्यूसरगंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • सेंट जॉन्स वॉर्टहर्बल और सप्लीमेंटगंभीर

    सेंट जॉन्स वॉर्ट इन दवाओं के टूटने की रफ़्तार बढ़ाकर इन्हें कमज़ोर कर सकता है, जिसका मतलब अंग की अस्वीकृति (रिजेक्शन), खून के थक्के या असर का खत्म होना हो सकता है। (NCCIH, St. John's Wort)

  • सेनोबामेटएंटीकन्वल्सेंट (दौरे की दवा)गंभीर

    John’s Wort reduce the bioavailability and efficacy of nifedipine; therefore nifedipine should not be used in combination with strong CYP3A inducers such as rifampin (See CONTRAINDICATIONS ). (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • सेफ्ट्रिएक्सोनसेफालोस्पोरिनगंभीर

    Do not administer simultaneously with calcium-containing IV solutions. (सेफ्ट्रिएक्सोन लेबल, चेतावनियां और सावधानियां)

मध्यम इंटरैक्शन (262)

  • अल्फुज़ोसिनअल्फा ब्लॉकरमध्यम

    Central Alpha1-Blockers Doxazosin: Healthy volunteers participating in a multiple dose doxazosin-nifedipine interaction study received 2 mg doxazosin q.d. alone or combined with 20 mg nifedipine ER b.i.d. Co-administration of nifedipine resulted in a decrease in AUC and C max of doxazosin to 83% and 86% of the values in the absence of nifedipine, respectively. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • Intervention: During concomitant use of CALDOLOR with diuretics, observe patients for signs of worsening renal function, in addition to assuring diuretic efficacy including antihypertensive effects [ see Warnings and Precautions ( 5.6 ) ]. (आइबुप्रोफेन लेबल, दवाओं के इंटरैक्शन)

  • Intervention: During concomitant use of ibuprofen and famotidine tablet with diuretics, observe patients for signs of worsening renal function, in addition to assuring diuretic efficacy including antihypertensive effects [see Warnings and Precautions ( 5.7 )] . (आइबुप्रोफेन और फैमोटिडीन लेबल, दवाओं के इंटरैक्शन)

  • आइवाकैफ्टरCYP3A4 इनहिबिटरमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • आइसोनियाज़िडएंटीबायोटिकमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • आइसोफ्लुरेनजनरल एनेस्थेटिकमध्यम

    Calcium Antagonists FORANE may lead to marked hypotension in patients treated with calcium antagonists. (आइसोफ्लुरेन लेबल, दवाओं के इंटरैक्शन)

  • Nifedipine is a vasodilator, and co-administration of other drugs affecting blood pressure may result in pharmacodynamic interactions. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • Nifedipine is a vasodilator, and co-administration of other drugs affecting blood pressure may result in pharmacodynamic interactions. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • Nifedipine is a vasodilator, and co-administration of other drugs affecting blood pressure may result in pharmacodynamic interactions. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • आर्गाट्रोबैनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    Antithrombotics Coumarins: There have been rare reports of increased prothrombin time in patients taking coumarin anticoagulants to whom nifedipine was administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • इंडापामाइडथायज़ाइड डाइयूरेटिकमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • Monitor patients to assure diuretic efficacy including antihypertensive effects ( 7 ) (इंडोमेथासिन लेबल, दवाओं के इंटरैक्शन)

  • इकोनाज़ोलएज़ोल एंटीफंगलमध्यम

    Non-Cardiovascular Drugs Antifungal Drugs Ketoconazole, itraconazole and fluconazole are CYP3A inhibitors and can inhibit the metabolism of nifedipine and increase the exposure to nifedipine during concomitant therapy. (निफेडिपिन लेबल, सावधानियां)

  • इबैंड्रोनेटबिस्फॉस्फोनेटमध्यम

    Instruct patients to take supplemental calcium and vitamin D if their dietary intake is inadequate (see Dosage and Administration [2.3] ) . (इबैंड्रोनेट लेबल, चेतावनियां और सावधानियां)

  • इमैटिनिबCYP3A4 इनहिबिटरमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • इर्बेसार्टन और हाइड्रोक्लोरोथायज़ाइडएंजियोटेंसिन II रिसेप्टर ब्लॉकर (ARB)मध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • इलोपेरिडोनएंटीसाइकोटिकमध्यम

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, and concomitant treatment with antihypertensive medications), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and… (इलोपेरिडोन लेबल, चेतावनियां और सावधानियां)

  • एकार्बोज़एंटीडायबिटिक (डायबिटीज़ की दवा)मध्यम

    If nifedipine is co-administered with acarbose, blood glucose levels should be monitored carefully and a dose adjustment of nifedipine considered. (निफेडिपिन लेबल, सावधानियां)

  • • If treatment with a gastric acid reducing agent is required, consider using a H2‑receptor antagonist (e.g., ranitidine or famotidine) or an antacid (e.g., calcium carbonate). (एकालाब्रुटिनिब लेबल, दवाओं के इंटरैक्शन)

  • एज़िथ्रोमाइसिनमैक्रोलाइड एंटीबायोटिकमध्यम

    CYP3A Inhibitors CYP3A inhibitors such as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure… (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • Amiodarone, Dronedarone, Ranolazine, or Calcium Channel Blockers Clinical Impact: The risk of myopathy and rhabdomyolysis is increased by concomitant use of amiodarone, dronedarone, ranolazine, or calcium channel blockers with VYTORIN. (एज़ेटिमाइब और सिमवास्टेटिन लेबल, दवाओं के इंटरैक्शन)

  • एटाज़ानाविरएंटीरेट्रोवायरलमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एटेनोलोलबीटा ब्लॉकरमध्यम

    These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment, and may be more likely in patients using concomitant beta-blockers. (निफेडिपिन लेबल, चेतावनियां)

  • एटेनोलोल और क्लोरथैलिडोनबीटा ब्लॉकरमध्यम

    These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment, and may be more likely in patients using concomitant beta-blockers. (निफेडिपिन लेबल, चेतावनियां)

  • एटोमोक्सेटिननॉरएपिनेफ्रिन रीअपटेक इनहिबिटरमध्यम

    Antihypertensive Drugs Prevention or Management Increase the frequency of monitoring blood pressure and adjust atomoxetine oral solution dosage as clinically appropriate. (एटोमोक्सेटिन लेबल, दवाओं के इंटरैक्शन)

  • एडोक्साबैनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    Antithrombotics Coumarins: There have been rare reports of increased prothrombin time in patients taking coumarin anticoagulants to whom nifedipine was administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एड्रेनालिनसिम्पैथोमिमेटिकमध्यम

    Epinephrine may antagonize the neuronal blockade produced by guanethidine resulting in decreased antihypertensive effect and requiring increased dosage of the latter. (एड्रेनालिन लेबल, दवाओं के इंटरैक्शन)

  • एथाक्रिनिक एसिडलूप डाइयूरेटिकमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एनालाप्रिलACE इनहिबिटरमध्यम

    ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एनालाप्रिलैटACE इनहिबिटरमध्यम

    ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एनोक्सापैरिनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    Antithrombotics Coumarins: There have been rare reports of increased prothrombin time in patients taking coumarin anticoagulants to whom nifedipine was administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एपिक्साबैनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    Antithrombotics Coumarins: There have been rare reports of increased prothrombin time in patients taking coumarin anticoagulants to whom nifedipine was administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • Following initiation and titration of Epogen, approximately 25% of patients on dialysis required initiation of or increases in antihypertensive therapy; hypertensive encephalopathy and seizures have been reported in patients with CKD receiving Epogen. (एपोएटिन अल्फा लेबल, चेतावनियां और सावधानियां)

  • एपोप्रोस्टेनोलप्रोस्टाग्लैंडिन एनालॉगमध्यम

    Nifedipine is a vasodilator, and co-administration of other drugs affecting blood pressure may result in pharmacodynamic interactions. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एप्लेरेनोनएल्डोस्टेरोन एंटागोनिस्टमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • …Interactions Concomitant Drug Class: Drug Name Effect on Concentration Increase = ↑; Decrease = ↓; No Effect = ↔ Clinical Comment Antacids: antacids (e.g., aluminum, magnesium hydroxide, or calcium carbonate) ↔ RPV (antacids taken at least 2 hours before or at least 4 hours after RPV) ↓ RPV (concomitant intake) Administer antacids at least 2 hours before or at least 4… (एमट्रिसिटाबिन, रिल्पिविरिन और टेनोफोविर लेबल, दवाओं के इंटरैक्शन)

  • एमियोडेरोनएंटीएरिदमिकमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एमिलोराइडपोटैशियम-स्पेयरिंग डाइयूरेटिकमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • Metformin: A single dose metformin-nifedipine interaction study in normal healthy volunteers demonstrated that co-administration of nifedipine increased plasma metformin C max and AUC by 20% and 9%, respectively, and increased the amount of metformin excreted in urine. (निफेडिपिन लेबल, सावधानियां)

  • एम्लोडिपिन और बेनाज़ेप्रिलडाइहाइड्रोपाइरिडीन कैल्शियम चैनल ब्लॉकरमध्यम

    ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एरिथ्रोमाइसिनमैक्रोलाइड एंटीबायोटिकमध्यम

    CYP3A Inhibitors CYP3A inhibitors such as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure… (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एरिपिप्राज़ोलएंटीसाइकोटिकमध्यम

    Antihypertensive Drugs Due to its alpha-adrenergic antagonism, aripiprazole has the potential to enhance the effect of certain antihypertensive agents. (एरिपिप्राज़ोल लेबल, दवाओं के इंटरैक्शन)

  • एलक्साडोलिनओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • Metformin: A single dose metformin-nifedipine interaction study in normal healthy volunteers demonstrated that co-administration of nifedipine increased plasma metformin C max and AUC by 20% and 9%, respectively, and increased the amount of metformin excreted in urine. (निफेडिपिन लेबल, सावधानियां)

  • एल्प्रोस्टाडिलप्रोस्टाग्लैंडिन एनालॉगमध्यम

    Nifedipine is a vasodilator, and co-administration of other drugs affecting blood pressure may result in pharmacodynamic interactions. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एवरोलिमसइम्यूनोसप्रेसेंटमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एवानाफिलPDE5 इनहिबिटरमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एसिटाज़ोलामाइडकार्बोनिक एनहाइड्रेज़ इनहिबिटरमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एसिब्यूटोलोलबीटा ब्लॉकरमध्यम

    These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment, and may be more likely in patients using concomitant beta-blockers. (निफेडिपिन लेबल, चेतावनियां)

  • एसेनापिनएंटीसाइकोटिकमध्यम

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (elderly patients, patients with dehydration, hypovolemia, concomitant treatment with antihypertensive medications, patients with known cardiovascular disease (history of myocardial infarction or ischemic heart disease, heart failure, or conduction abnormalities), and patients… (एसेनापिन लेबल, चेतावनियां और सावधानियां)

  • Beta Blocker and Calcium Channel Blockers : dose adjustment of beta blockers or calcium channel blockers may be necessary (‎ 7 ). (ऑक्ट्रियोटाइड लेबल, दवाओं के इंटरैक्शन)

  • Intervention: During concomitant use of OXAPROZIN CAPSULES with diuretics, observe patients for signs of worsening renal function, in addition to assuring diuretic efficacy including antihypertensive effects [see WARNINGS AND PRECAUTIONS (5.6) ]. (ऑक्साप्रोज़िन लेबल, दवाओं के इंटरैक्शन)

  • ऑक्सीकोडोनओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • ऑक्सीमॉर्फोनओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • ओमेप्राज़ोलप्रोटॉन पंप इनहिबिटरमध्यम

    Antisecretory Drugs Omeprazole: In healthy volunteers receiving a single dose of 10 mg nifedipine, AUC and C max of nifedipine after pre-treatment with omeprazole 20 mg q.d. for 8 days were 1.26 and 0.87 times those after pre-treatment with placebo. (निफेडिपिन लेबल, सावधानियां)

  • ओमेप्राज़ोल और सोडियम बाइकार्बोनेटप्रोटॉन पंप इनहिबिटरमध्यम

    Antisecretory Drugs Omeprazole: In healthy volunteers receiving a single dose of 10 mg nifedipine, AUC and C max of nifedipine after pre-treatment with omeprazole 20 mg q.d. for 8 days were 1.26 and 0.87 times those after pre-treatment with placebo. (निफेडिपिन लेबल, सावधानियां)

  • ओलिसेरिडिनओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • ओलैंज़ापिनएंटीसाइकोटिकमध्यम

    …of myocardial infarction or ischemia, heart failure, or conduction abnormalities), cerebrovascular disease, and conditions which would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications) where the occurrence of syncope, or hypotension and/or bradycardia might put the patient at increased medical risk. (ओलैंज़ापिन लेबल, चेतावनियां और सावधानियां)

  • ओलैंज़ापिन और फ्लुओक्सेटिनएंटीसाइकोटिकमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ओल्मेसार्टन और हाइड्रोक्लोरोथायज़ाइडएंजियोटेंसिन II रिसेप्टर ब्लॉकर (ARB)मध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ओल्मेसार्टन, एम्लोडिपिन और हाइड्रोक्लोरोथायज़ाइडएंजियोटेंसिन II रिसेप्टर ब्लॉकर (ARB)मध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • Symptomatic postural hypotension has occurred when carbidopa, given with levodopa or carbidopa-levodopa combination products, was added to the treatment of a patient receiving antihypertensive drugs. (कार्बिडोपा लेबल, दवाओं के इंटरैक्शन)

  • कार्बिडोपा और लेवोडोपाडोपामिनर्जिक दवामध्यम

    Antihypertensive drugs: May cause symptomatic postural hypotension. (कार्बिडोपा और लेवोडोपा लेबल, दवाओं के इंटरैक्शन)

  • कार्बिडोपा, लेवोडोपा और एंटाकैपोनडोपामिनर्जिक दवामध्यम

    Antihypertensive Agents Symptomatic postural hypotension has occurred when carbidopa/levodopa was added to the treatment of patients receiving antihypertensive drugs. (कार्बिडोपा, लेवोडोपा और एंटाकैपोन लेबल, दवाओं के इंटरैक्शन)

  • कार्वेडिलोलबीटा ब्लॉकरमध्यम

    These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment, and may be more likely in patients using concomitant beta-blockers. (निफेडिपिन लेबल, चेतावनियां)

  • कीटोकोनाज़ोलएज़ोल एंटीफंगलमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • कैंडेसार्टन और हाइड्रोक्लोरोथायज़ाइडएंजियोटेंसिन II रिसेप्टर ब्लॉकर (ARB)मध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • कैप्टोप्रिलACE इनहिबिटरमध्यम

    ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • कैरिप्राज़िनएंटीसाइकोटिकमध्यम

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, and concomitant treatment with antihypertensive medications), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and… (कैरिप्राज़िन लेबल, चेतावनियां और सावधानियां)

  • Calcium Channel Blockers : Administration of calcium may reduce the response. (कैल्शियम ग्लूकोनेट लेबल, दवाओं के इंटरैक्शन)

  • कोडीनओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • क्लोट्रिमाज़ोलएज़ोल एंटीफंगलमध्यम

    Non-Cardiovascular Drugs Antifungal Drugs Ketoconazole, itraconazole and fluconazole are CYP3A inhibitors and can inhibit the metabolism of nifedipine and increase the exposure to nifedipine during concomitant therapy. (निफेडिपिन लेबल, सावधानियां)

  • क्लोनिडिनअल्फा-एड्रीनर्जिक एगोनिस्टमध्यम

    Drugs that affect sinus node function or AV node conduction (e.g., digitalis, calcium channel blockers, beta blockers) Clinical Implication Concomitant use of drugs that affect sinus node function or AV node conduction with clonidine potentiate bradycardia and risk of AV block [see Warnings and Precautions (5.1) ]. (क्लोनिडिन लेबल, दवाओं के इंटरैक्शन)

  • क्लोरथैलिडोनथायज़ाइड डाइयूरेटिकमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • क्लोरोथायज़ाइडथायज़ाइड डाइयूरेटिकमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • क्विनाप्रिलACE इनहिबिटरमध्यम

    ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • क्विनिडिनएंटीएरिदमिकमध्यम

    Co-administration of multiple doses of quinidine sulfate, 200 mg t.i.d., and nifedipine, 20 mg t.i.d., increased C max and AUC of nifedipine in healthy volunteers by factors of 2.30 and 1.37, respectively. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • क्वेटियापिनएंटीसाइकोटिकमध्यम

    Quetiapine should be used with particular caution in patients with known cardiovascular disease (history of myocardial infarction or ischemic heart disease, heart failure, or conduction abnormalities), cerebrovascular disease, or conditions which would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications). (क्वेटियापिन लेबल, चेतावनियां और सावधानियां)

  • ग्लिपिज़ाइड और मेटफॉर्मिनसल्फोनिलयूरियामध्यम

    Metformin: A single dose metformin-nifedipine interaction study in normal healthy volunteers demonstrated that co-administration of nifedipine increased plasma metformin C max and AUC by 20% and 9%, respectively, and increased the amount of metformin excreted in urine. (निफेडिपिन लेबल, सावधानियां)

  • ग्लिबेनक्लामाइड और मेटफॉर्मिनसल्फोनिलयूरियामध्यम

    Metformin: A single dose metformin-nifedipine interaction study in normal healthy volunteers demonstrated that co-administration of nifedipine increased plasma metformin C max and AUC by 20% and 9%, respectively, and increased the amount of metformin excreted in urine. (निफेडिपिन लेबल, सावधानियां)

  • ज़िप्रासिडोनएंटीसाइकोटिकमध्यम

    Ziprasidone should be used with particular caution in patients with known cardiovascular disease (history of myocardial infarction or ischemic heart disease, heart failure or conduction abnormalities), cerebrovascular disease, or conditions which would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications). (ज़िप्रासिडोन लेबल, चेतावनियां और सावधानियां)

  • टिकाग्रेलोरएंटीप्लेटलेट दवामध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • टिमोलोलबीटा ब्लॉकरमध्यम

    Timolol: Hypotension is more likely to occur if dihydropryridine calcium antagonists such as nifedipine are co-administered with timolol. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • टेपेंटाडोलओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine). (टेम्सिरोलिमस लेबल, दवाओं के इंटरैक्शन)

  • टेराज़ोसिनअल्फा ब्लॉकरमध्यम

    Central Alpha1-Blockers Doxazosin: Healthy volunteers participating in a multiple dose doxazosin-nifedipine interaction study received 2 mg doxazosin q.d. alone or combined with 20 mg nifedipine ER b.i.d. Co-administration of nifedipine resulted in a decrease in AUC and C max of doxazosin to 83% and 86% of the values in the absence of nifedipine, respectively. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • टेल्मिसार्टन और हाइड्रोक्लोरोथायज़ाइडएंजियोटेंसिन II रिसेप्टर ब्लॉकर (ARB)मध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • टेस्टोस्टेरोनएंड्रोजनमध्यम

    In patients with hypertension on antihypertensive therapy, TLANDO increased the mean systolic/diastolic BP by 4.8/1.6 mm Hg from baseline. [see Adverse Reactions ( 6.1 )] . (टेस्टोस्टेरोन लेबल, चेतावनियां और सावधानियां)

  • टैक्रोलिमसइम्यूनोसप्रेसेंटमध्यम

    Transplant patients on tacrolimus and nifedipine required from 26% to 38% smaller doses than patients not receiving nifedipine. (निफेडिपिन लेबल, सावधानियां)

  • टैम्सुलोसिनअल्फा ब्लॉकरमध्यम

    Central Alpha1-Blockers Doxazosin: Healthy volunteers participating in a multiple dose doxazosin-nifedipine interaction study received 2 mg doxazosin q.d. alone or combined with 20 mg nifedipine ER b.i.d. Co-administration of nifedipine resulted in a decrease in AUC and C max of doxazosin to 83% and 86% of the values in the absence of nifedipine, respectively. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • टॉरसेमाइडलूप डाइयूरेटिकमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ट्रामाडोलओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • ट्रायमटेरिनपोटैशियम-स्पेयरिंग डाइयूरेटिकमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ट्रायमटेरिन और हाइड्रोक्लोरोथायज़ाइडपोटैशियम-स्पेयरिंग डाइयूरेटिकमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ट्रेप्रोस्टिनिलप्रोस्टाग्लैंडिन एनालॉगमध्यम

    Nifedipine is a vasodilator, and co-administration of other drugs affecting blood pressure may result in pharmacodynamic interactions. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ट्रैंडोलाप्रिलACE इनहिबिटरमध्यम

    ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ट्रैज़ोडोनएंटीडिप्रेसेंटमध्यम

    Concomitant use with an antihypertensive may require a reduction in the dose of the antihypertensive drug. (ट्रैज़ोडोन लेबल, चेतावनियां और सावधानियां)

  • डाइएथिलप्रोपियॉनCNS स्टिमुलेंटमध्यम

    The pressor effects of diethylpropion and those of other drugs may be additive when the drugs are used concomitantly; conversely, diethylpropion may interfere with antihypertensive drugs (i.e., guanethidine, a-methyldopa). (डाइएथिलप्रोपियॉन लेबल, दवाओं के इंटरैक्शन)

  • Intervention: During concomitant use of ZIPSOR with diuretics, observe patients for signs of worsening renal function, in addition to assuring diuretic efficacy including antihypertensive effects [ see Warnings and Precautions ( 5.6 ) ]. (डाइक्लोफेनाक लेबल, दवाओं के इंटरैक्शन)

  • Intervention: During concomitant use of diclofenac sodium/misoprostol with diuretics, observe patients for signs of worsening renal function, in addition to assuring diuretic efficacy including antihypertensive effects [see Warnings and Precautions (5.7) ] . (डाइक्लोफेनाक और मिसोप्रोस्टोल लेबल, दवाओं के इंटरैक्शन)

  • डारुनाविरएंटीरेट्रोवायरलमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • डारुनाविर और कोबिसिस्टैटएंटीरेट्रोवायरलमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • डिल्टियाज़ेमकैल्शियम चैनल ब्लॉकरमध्यम

    Calcium Channel Blockers Diltiazem: Pre-treatment of healthy volunteers with 30 mg or 90 mg t.i.d. diltiazem p.o. increased the AUC of nifedipine after a single dose of 20 mg nifedipine by factors of 2.2 and 3.1, respectively. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • The risk of BP decreases may be greater in patients taking concomitant medications that induce orthostatic hypotension (such as antihypertensives) or are potent CYP1A2 inhibitors [see Drug Interactions ( 7.1 )] and in patients taking duloxetine delayed-release capsules at doses above 60 mg daily. (डुलोक्सेटिन लेबल, चेतावनियां और सावधानियां)

  • डेक्सट्रोमेथॉर्फन और क्विनिडिनसेरोटोनर्जिक दवामध्यम

    Co-administration of multiple doses of quinidine sulfate, 200 mg t.i.d., and nifedipine, 20 mg t.i.d., increased C max and AUC of nifedipine in healthy volunteers by factors of 2.30 and 1.37, respectively. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • डेक्समिथाइलफेनिडेटCNS स्टिमुलेंटमध्यम

    • Antihypertensive Drugs: Monitor blood pressure. (डेक्समिथाइलफेनिडेट लेबल, दवाओं के इंटरैक्शन)

  • Metformin: A single dose metformin-nifedipine interaction study in normal healthy volunteers demonstrated that co-administration of nifedipine increased plasma metformin C max and AUC by 20% and 9%, respectively, and increased the amount of metformin excreted in urine. (निफेडिपिन लेबल, सावधानियां)

  • डैबिगैट्रानएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    Antithrombotics Coumarins: There have been rare reports of increased prothrombin time in patients taking coumarin anticoagulants to whom nifedipine was administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • डॉक्सरकैल्सिफेरॉलविटामिन D एनालॉगमध्यम

    Hypercalcemia may be exacerbated by concomitant administration of high doses of calcium-containing preparations, thiazide diuretics, or other vitamin D compounds [see Drug Interactions ( 7 )]. (डॉक्सरकैल्सिफेरॉल लेबल, चेतावनियां और सावधानियां)

  • डॉक्साज़ोसिनअल्फा ब्लॉकरमध्यम

    In the presence of doxazosin, AUC and C max of nifedipine were increased by factors of 1.13 and 1.23, respectively. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • डोफेटिलाइडएंटीएरिदमिकमध्यम

    Concomitant medications were grouped as ACE inhibitors, oral anticoagulants, calcium channel blockers, beta blockers, cardiac glycosides, inducers of CYP3A4, substrates and inhibitors of CYP3A4, substrates and inhibitors of P-glycoprotein, nitrates, sulphonylureas, loop diuretics, potassium sparing diuretics, thiazide diuretics, substrates and inhibitors of tubular… (डोफेटिलाइड लेबल, दवाओं के इंटरैक्शन)

  • डोरज़ोलामाइड और टिमोलोलकार्बोनिक एनहाइड्रेज़ इनहिबिटरमध्यम

    Timolol: Hypotension is more likely to occur if dihydropryridine calcium antagonists such as nifedipine are co-administered with timolol. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ड्यूटास्टेराइड5-अल्फा रिडक्टेज़ इनहिबिटरमध्यम

    Calcium Channel Antagonists Coadministration of verapamil or diltiazem decreases dutasteride clearance and leads to increased exposure to dutasteride. (ड्यूटास्टेराइड लेबल, दवाओं के इंटरैक्शन)

  • ड्यूटास्टेराइड और टैम्सुलोसिन5-अल्फा रिडक्टेज़ इनहिबिटरमध्यम

    Central Alpha1-Blockers Doxazosin: Healthy volunteers participating in a multiple dose doxazosin-nifedipine interaction study received 2 mg doxazosin q.d. alone or combined with 20 mg nifedipine ER b.i.d. Co-administration of nifedipine resulted in a decrease in AUC and C max of doxazosin to 83% and 86% of the values in the absence of nifedipine, respectively. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ड्रोनेडेरोनएंटीएरिदमिकमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ड्रोपेरिडोलडोपामिन एंटागोनिस्टमध्यम

    Possible pharmacodynamic interactions can occur between droperidol and potentially arrhythmogenic agents such as class I or III antiarrhythmics, antihistamines that prolong the QT interval, antimalarials, calcium channel blockers, neuroleptics that prolong the QT interval, and antidepressants. (ड्रोपेरिडोल लेबल, दवाओं के इंटरैक्शन)

  • नाइट्रोग्लिसरीननाइट्रेटमध्यम

    Nifedipine is a vasodilator, and co-administration of other drugs affecting blood pressure may result in pharmacodynamic interactions. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • नाइट्रोप्रुसाइडवैसोडाइलेटरमध्यम

    Nifedipine is a vasodilator, and co-administration of other drugs affecting blood pressure may result in pharmacodynamic interactions. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • नाडोलोलबीटा ब्लॉकरमध्यम

    These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment, and may be more likely in patients using concomitant beta-blockers. (निफेडिपिन लेबल, चेतावनियां)

  • नालबुफिनओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • निमोडिपिनडाइहाइड्रोपाइरिडीन कैल्शियम चैनल ब्लॉकरमध्यम

    Blood Pressure Lowering Drugs Nimodipine may increase the blood pressure lowering effect of concomitantly administered anti-hypertensives such as diuretics, beta-blockers, ACE inhibitors, angiotensin receptor blockers, other calcium channel blockers, α-adrenergic blockers, PDE5 inhibitors, and α-methyldopa. (निमोडिपिन लेबल, दवाओं के इंटरैक्शन)

  • नियासिनमध्यम

    Caution should also be used when niacin extended-release tablets are used in patients with unstable angina or in the acute phase of an MI, particularly when such patients are also receiving vasoactive drugs such as nitrates, calcium channel blockers, or adrenergic blocking agents. (नियासिन लेबल, चेतावनियां और सावधानियां)

  • …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ( 5.3 Hepatotoxicity) Hypertension: Patients taking some antihypertensive medications may have impaired response to these therapies when taking NSAIDs. (नेप्रोक्सेन लेबल, चेतावनियां और सावधानियां)

  • Intervention : During concomitant use of naproxen and esomeprazole magnesium delayed-release tablets with diuretics, observe patients for signs of worsening renal function, in addition to assuring diuretic efficacy including antihypertensive effects [see Warnings and Precautions (5.6) ]. (नेप्रोक्सेन और एसोमेप्राज़ोल लेबल, दवाओं के इंटरैक्शन)

  • नेफाज़ोडोनएंटीडिप्रेसेंटमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • नेबिवोलोलबीटा ब्लॉकरमध्यम

    These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment, and may be more likely in patients using concomitant beta-blockers. (निफेडिपिन लेबल, चेतावनियां)

  • Monitor patients to assure diuretic efficacy including antihypertensive effects (7) (पाइरोक्सिकैम लेबल, दवाओं के इंटरैक्शन)

  • Monitor blood pressure as clinically indicated and initiate and adjust antihypertensive therapy as appropriate. (पाज़ोपैनिब लेबल, चेतावनियां और सावधानियां)

  • पाल्बोसिक्लिबCYP3A4 इनहिबिटरमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • पिंडोलोलबीटा ब्लॉकरमध्यम

    These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment, and may be more likely in patients using concomitant beta-blockers. (निफेडिपिन लेबल, चेतावनियां)

  • पियोग्लिटाज़ोन और मेटफॉर्मिनथायज़ोलिडिनडायोनमध्यम

    Metformin: A single dose metformin-nifedipine interaction study in normal healthy volunteers demonstrated that co-administration of nifedipine increased plasma metformin C max and AUC by 20% and 9%, respectively, and increased the amount of metformin excreted in urine. (निफेडिपिन लेबल, सावधानियां)

  • The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • पेंटोक्सिफाइलिनमिथाइलज़ैंथिनमध्यम

    Small decreases in blood pressure have been observed in some patients treated with pentoxifylline extended-release tablets; periodic systemic blood pressure monitoring is recommended for patients receiving concomitant antihypertensive therapy. (पेंटोक्सिफाइलिन लेबल, दवाओं के इंटरैक्शन)

  • पेथिडीनओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • पेरिंडोप्रिलACE इनहिबिटरमध्यम

    ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • पेरैम्पेनलएंटीकन्वल्सेंट (दौरे की दवा)मध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • पैपावेरिनवैसोडाइलेटरमध्यम

    Nifedipine is a vasodilator, and co-administration of other drugs affecting blood pressure may result in pharmacodynamic interactions. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • • Hypertension : Patients taking some antihypertensive medications may have impaired response to these therapies when taking NSAIDs. (पैरासिटामोल और आइबुप्रोफेन लेबल, चेतावनियां और सावधानियां)

  • The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • पैरिकैल्सिटोलविटामिन D एनालॉगमध्यम

    Hypercalcemia may be exacerbated by concomitant administration of high doses of calcium-containing preparations, thiazide diuretics, or other vitamin D compounds [see Drug Interactions (7) ] . (पैरिकैल्सिटोल लेबल, चेतावनियां और सावधानियां)

  • पैलिपेरिडोनएंटीसाइकोटिकमध्यम

    Use ERZOFRI with caution in patients with known cardiovascular disease (e.g., heart failure, history of myocardial infarction or ischemia, conduction abnormalities), cerebrovascular disease, or conditions that predispose the patient to hypotension (e.g., dehydration, hypovolemia, and treatment with antihypertensive medications). (पैलिपेरिडोन लेबल, चेतावनियां और सावधानियां)

  • Adjustments in the dose of drugs known to slow the heart rate (e.g., beta-blockers, calcium channel blockers) and correction of electrolyte disturbances may be necessary when initiating or during the course of SIGNIFOR LAR treatment. (पैसिरियोटाइड लेबल, चेतावनियां और सावधानियां)

  • पोनेसिमोडइम्यूनोसप्रेसेंटमध्यम

    Experience with PONVORY is limited in patients receiving concurrent therapy with drugs that decrease heart rate (e.g., beta-blockers, non-dihydropyridine calcium channel blockers - diltiazem and verapamil, and other drugs that may decrease heart rate such as digoxin). (पोनेसिमोड लेबल, चेतावनियां और सावधानियां)

  • पोसाकोनाज़ोलएज़ोल एंटीफंगलमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • प्राज़ोसिनअल्फा ब्लॉकरमध्यम

    Central Alpha1-Blockers Doxazosin: Healthy volunteers participating in a multiple dose doxazosin-nifedipine interaction study received 2 mg doxazosin q.d. alone or combined with 20 mg nifedipine ER b.i.d. Co-administration of nifedipine resulted in a decrease in AUC and C max of doxazosin to 83% and 86% of the values in the absence of nifedipine, respectively. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • प्रोप्रानोलोलबीटा ब्लॉकरमध्यम

    These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment, and may be more likely in patients using concomitant beta-blockers. (निफेडिपिन लेबल, चेतावनियां)

  • The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • फिडैक्सोमाइसिनमैक्रोलाइड एंटीबायोटिकमध्यम

    CYP3A Inhibitors CYP3A inhibitors such as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure… (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • फिनाइलएफ्रिनडीकंजेस्टेंटमध्यम

    Antagonistic Effects (decrease in BIORPHEN blood pressure effect) can occur with α-adrenergic antagonists, phosphodiesterase Type 5 inhibitors, mixed α- and β-receptor antagonists, calcium channel blockers, benzodiazepines and ACE inhibitors, centrally acting sympatholytic agents. (फिनाइलएफ्रिन लेबल, दवाओं के इंटरैक्शन)

  • फेंटानिलओपिओइडमध्यम

    Severe hypotension and/or increased fluid volume requirements have been reported in patients who received immediate-release capsules together with a beta-blocking agent and who underwent coronary artery bypass surgery using high-dose fentanyl anesthesia. (निफेडिपिन लेबल, चेतावनियां)

  • फेंटोलामिनअल्फा ब्लॉकरमध्यम

    Central Alpha1-Blockers Doxazosin: Healthy volunteers participating in a multiple dose doxazosin-nifedipine interaction study received 2 mg doxazosin q.d. alone or combined with 20 mg nifedipine ER b.i.d. Co-administration of nifedipine resulted in a decrease in AUC and C max of doxazosin to 83% and 86% of the values in the absence of nifedipine, respectively. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • फेनेलज़िनMAO इनहिबिटरमध्यम

    …hydrochloride desipramine hydrochloride imipramine hydrochloride doxepin carbamazepine cyclobenzaprine HCl amoxapine maprotiline HCl trimipramine maleate protriptyline HCl mirtazapine Phenelzine sulfate should be used with caution in combination with antihypertensive drugs, including thiazide diuretics and β-blockers, since exaggerated hypotensive effects may result. (फेनेलज़िन लेबल, चेतावनियां)

  • फेनोक्सीबेंज़ामिनअल्फा ब्लॉकरमध्यम

    Central Alpha1-Blockers Doxazosin: Healthy volunteers participating in a multiple dose doxazosin-nifedipine interaction study received 2 mg doxazosin q.d. alone or combined with 20 mg nifedipine ER b.i.d. Co-administration of nifedipine resulted in a decrease in AUC and C max of doxazosin to 83% and 86% of the values in the absence of nifedipine, respectively. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • Intervention: During concomitant use of FENOPROFEN CALCIUM with diuretics, observe patients for signs of worsening renal function, in addition to assuring diuretic efficacy including antihypertensive effects [ see Warnings and Precautions ( 5.6 ) ]. (फेनोप्रोफेन लेबल, दवाओं के इंटरैक्शन)

  • Alternative antihypertensive therapy should be considered in patients taking phenytoin, phenobarbital, and carbamazepine. (निफेडिपिन लेबल, सावधानियां)

  • फोंडापैरिनक्सएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    Antithrombotics Coumarins: There have been rare reports of increased prothrombin time in patients taking coumarin anticoagulants to whom nifedipine was administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • फोसएम्प्रेनाविरएंटीरेट्रोवायरलमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • फोसाप्रेपिटेंटCYP3A4 इनहिबिटरमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • फोसिनोप्रिलACE इनहिबिटरमध्यम

    ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • फ्यूरोसेमाइडलूप डाइयूरेटिकमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • Intervention: During concomitant use of flurbiprofen with diuretics, observe patients for signs of worsening renal function, in addition to assuring diuretic efficacy including antihypertensive effects [ see Warnings and Precautions (5) ]. (फ्लर्बिप्रोफेन लेबल, दवाओं के इंटरैक्शन)

  • …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • फ्लुकोनाज़ोलएज़ोल एंटीफंगलमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • बिवालिरुडिनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    Antithrombotics Coumarins: There have been rare reports of increased prothrombin time in patients taking coumarin anticoagulants to whom nifedipine was administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • बिसोप्रोलोलबीटा ब्लॉकरमध्यम

    These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment, and may be more likely in patients using concomitant beta-blockers. (निफेडिपिन लेबल, चेतावनियां)

  • These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment, and may be more likely in patients using concomitant beta-blockers. (निफेडिपिन लेबल, चेतावनियां)

  • बुमेटेनाइडलूप डाइयूरेटिकमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • बेंज़फेटामाइनCNS स्टिमुलेंटमध्यम

    Amphetamines may decrease the hypotensive effect of antihypertensives. (बेंज़फेटामाइन लेबल, दवाओं के इंटरैक्शन)

  • बेनाज़ेप्रिलACE इनहिबिटरमध्यम

    ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • बेलाडोना और ओपियमओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • Hypotension: Use caution when treating patients taking antihypertensives, with a history of syncope, or with dehydration. (बोर्टेज़ोमिब लेबल, चेतावनियां और सावधानियां)

  • The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • ब्यूटॉर्फेनॉलओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • ब्यूप्रेनॉर्फिनओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • ब्रिमोनिडिनअल्फा-एड्रीनर्जिक एगोनिस्टमध्यम

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (ब्रिमोनिडिन लेबल, दवाओं के इंटरैक्शन)

  • ब्रिमोनिडिन और टिमोलोलअल्फा-एड्रीनर्जिक एगोनिस्टमध्यम

    Timolol: Hypotension is more likely to occur if dihydropryridine calcium antagonists such as nifedipine are co-administered with timolol. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ब्रेक्सपिप्राज़ोलएंटीसाइकोटिकमध्यम

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, concomitant treatment with antihypertensive medication), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and… (ब्रेक्सपिप्राज़ोल लेबल, चेतावनियां और सावधानियां)

  • Central Nervous System (CNS) depressants Antihistamines have additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, antianxiety agents, etc.). Antihypertensive drugs Sympathomimetic may reduce the effects of antihypertensive drugs. (ब्रोमफेनिरामिन, स्यूडोएफेड्रिन और डेक्सट्रोमेथॉर्फन लेबल, दवाओं के इंटरैक्शन)

  • ब्रोमोक्रिप्टिनडोपामिन एगोनिस्टमध्यम

    Use caution in patients taking antihypertensive medications. (ब्रोमोक्रिप्टिन लेबल, चेतावनियां और सावधानियां)

  • माइकाफंगिनएंटीफंगलमध्यम

    Monitor for sirolimus, itraconazole or nifedipine toxicity, and dosage of sirolimus, itraconazole or nifedipine should be reduced, if necessary. (माइकाफंगिन लेबल, दवाओं के इंटरैक्शन)

  • माइकोनाज़ोलएज़ोल एंटीफंगलमध्यम

    Non-Cardiovascular Drugs Antifungal Drugs Ketoconazole, itraconazole and fluconazole are CYP3A inhibitors and can inhibit the metabolism of nifedipine and increase the exposure to nifedipine during concomitant therapy. (निफेडिपिन लेबल, सावधानियां)

  • मिथाइलडोपाएंटीहाइपरटेंसिव (ब्लड प्रेशर की दवा)मध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • मिथाइलफेनिडेटCNS स्टिमुलेंटमध्यम

    Antihypertensive Drugs: Monitor blood pressure. (मिथाइलफेनिडेट लेबल, दवाओं के इंटरैक्शन)

  • मिफेप्रिस्टोनCYP3A4 इनहिबिटरमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • मिराबेग्रॉनबीटा-एड्रीनर्जिक एगोनिस्टमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • मिर्टाज़ापिनएंटीडिप्रेसेंटमध्यम

    REMERON/REMERONSolTab should be used with caution in patients with known cardiovascular or cerebrovascular disease that could be exacerbated by hypotension (history of myocardial infarction, angina, or ischemic stroke) and conditions that would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medication). (मिर्टाज़ापिन लेबल, चेतावनियां और सावधानियां)

  • मेकामाइलामिनएंटीहाइपरटेंसिव (ब्लड प्रेशर की दवा)मध्यम

    The action of Mecamylamine HCl may be potentiated by anesthesia, other antihypertensive drugs and alcohol. (मेकामाइलामिन लेबल, दवाओं के इंटरैक्शन)

  • मेटफॉर्मिनबाइगुआनाइडमध्यम

    Metformin: A single dose metformin-nifedipine interaction study in normal healthy volunteers demonstrated that co-administration of nifedipine increased plasma metformin C max and AUC by 20% and 9%, respectively, and increased the amount of metformin excreted in urine. (निफेडिपिन लेबल, सावधानियां)

  • मेटोप्रोलोलबीटा ब्लॉकरमध्यम

    These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment, and may be more likely in patients using concomitant beta-blockers. (निफेडिपिन लेबल, चेतावनियां)

  • These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment, and may be more likely in patients using concomitant beta-blockers. (निफेडिपिन लेबल, चेतावनियां)

  • मेथाडोनओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • Intervention: During concomitant use of mefenamic acid with diuretics, observe patients for signs of worsening renal function, in addition to assuring diuretic efficacy including antihypertensive effects [see Warnings and Precautions ( 5.6 )] . (मेफेनामिक एसिड लेबल, दवाओं के इंटरैक्शन)

  • मेफ्लोक्वीनमलेरिया-रोधी दवामध्यम

    Other Drugs that Prolong the QTc Interval Coadministration of other drugs known to alter cardiac conduction (e.g., anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H 1 -blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval. (मेफ्लोक्वीन लेबल, दवाओं के इंटरैक्शन)

  • Intervention: During concomitant use of QAMZOVA with diuretics, observe patients for signs of worsening renal function, in addition to assuring diuretic efficacy including antihypertensive effects [ see Warnings and Precautions ( 5.6 ) ]. (मेलोक्सिकैम लेबल, दवाओं के इंटरैक्शन)

  • मॉर्फिनओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • मोएक्सिप्रिलACE इनहिबिटरमध्यम

    ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • रियोसिगुआटवैसोडाइलेटरमध्यम

    Nifedipine is a vasodilator, and co-administration of other drugs affecting blood pressure may result in pharmacodynamic interactions. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • रिल्पिविरिनएंटीरेट्रोवायरलमध्यम

    …Drug Name Effect on Concentration of Rilpivirine or Concomitant Drug Clinical Comment ↑=increase, ↓=decrease, ↔=no change Antacids: antacids (e.g., aluminum or magnesium hydroxide, calcium carbonate) ↔ rilpivirine (antacids taken at least 2 hours before or at least 4 hours after rilpivirine) The combination of EDURANT or EDURANT PED and antacids should be used… (रिल्पिविरिन लेबल, दवाओं के इंटरैक्शन)

  • रिवारोक्साबैनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    Antithrombotics Coumarins: There have been rare reports of increased prothrombin time in patients taking coumarin anticoagulants to whom nifedipine was administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • रिसेड्रोनेटबिस्फॉस्फोनेटमध्यम

    Calcium Supplements/Antacids When Risedronate sodium delayed-release was administered following breakfast, the co-administration of a tablet containing 600 mg of elemental calcium and 400 international units vitamin D reduced risedronate bioavailability by approximately 38% [ see Clinical Pharmacology (12.3) ] . (रिसेड्रोनेट लेबल, दवाओं के इंटरैक्शन)

  • रिस्पेरिडोनएंटीसाइकोटिकमध्यम

    Clinically significant hypotension has been observed with concomitant use of oral RISPERDAL and antihypertensive medication. (रिस्पेरिडोन लेबल, चेतावनियां और सावधानियां)

  • रेपाग्लिनाइडमेग्लिटिनाइडमध्यम

    Repaglinide: Co-administration of 10 mg nifedipine with a single dose of 2 mg repaglinide (after 4 days nifedipine 10 mg t.i.d. and repaglinide 2 mg t.i.d.) resulted in unchanged AUC and C max values for both drugs. (निफेडिपिन लेबल, सावधानियां)

  • रेमिफेंटानिलओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • रैनिटिडीनH2 ब्लॉकरमध्यम

    Ranitidine: Five studies in healthy volunteers investigated the impact of multiple ranitidine doses on the single or multiple dose pharmacokinetics of nifedipine. (निफेडिपिन लेबल, सावधानियां)

  • रैनोलाज़िनQT अंतराल बढ़ाने वाली दवामध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • रैमिप्रिलACE इनहिबिटरमध्यम

    ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • लिथियमसेरोटोनर्जिक दवामध्यम

    Calcium Channel Blocking Agents (CCB) Clinical Impact: Concomitant use may increase the risk of neurologic adverse reactions in the form of ataxia, tremors, nausea, vomiting, diarrhea and/or tinnitus. (लिथियम लेबल, दवाओं के इंटरैक्शन)

  • Metformin: A single dose metformin-nifedipine interaction study in normal healthy volunteers demonstrated that co-administration of nifedipine increased plasma metformin C max and AUC by 20% and 9%, respectively, and increased the amount of metformin excreted in urine. (निफेडिपिन लेबल, सावधानियां)

  • लिसिनोप्रिलACE इनहिबिटरमध्यम

    ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ACE Inhibitors Benazepril: In healthy volunteers receiving single dose of 20 mg nifedipine ER and benazepril 10 mg, the plasma concentrations of benazeprilat and nifedipine in the presence and absence of each other were not statistically significantly different. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • लुमाटेपेरोनएंटीसाइकोटिकमध्यम

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, and concomitant treatment with antihypertensive drugs), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and patients… (लुमाटेपेरोन लेबल, चेतावनियां और सावधानियां)

  • लेनाकैपाविरएंटीरेट्रोवायरलमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • लेवॉर्फेनॉलओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • लैकोसामाइडएंटीकन्वल्सेंट (दौरे की दवा)मध्यम

    VIMPAT should also be used with caution in patients on concomitant medications that affect cardiac conduction, including sodium channel blockers, beta-blockers, calcium channel blockers, potassium channel blockers, and medications that prolong the PR interval [see Drug Interactions (7.2) ] . (लैकोसामाइड लेबल, चेतावनियां और सावधानियां)

  • लोसार्टन और हाइड्रोक्लोरोथायज़ाइडएंजियोटेंसिन II रिसेप्टर ब्लॉकर (ARB)मध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ल्यूरासिडोनएंटीसाइकोटिकमध्यम

    Patients at increased risk of these adverse reactions or at increased risk of developing complications from hypotension include those with dehydration, hypovolemia, treatment with antihypertensive medication, history of cardiovascular disease (e.g., heart failure, myocardial infarction, ischemia, or conduction abnormalities), history of cerebrovascular disease,… (ल्यूरासिडोन लेबल, चेतावनियां और सावधानियां)

  • वारफेरिनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    Antithrombotics Coumarins: There have been rare reports of increased prothrombin time in patients taking coumarin anticoagulants to whom nifedipine was administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • वार्डेनाफिलPDE5 इनहिबिटरमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • वाल्सार्टन और हाइड्रोक्लोरोथायज़ाइडएंजियोटेंसिन II रिसेप्टर ब्लॉकर (ARB)मध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • Metoprolol: Possibly reduced blood-pressure lowering effect despite increased metoprolol plasma levels. (वेनलाफैक्सिन लेबल, दवाओं के इंटरैक्शन)

  • वेरापामिलकैल्शियम चैनल ब्लॉकरमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • वेरिसिगुआटवैसोडाइलेटरमध्यम

    Nifedipine is a vasodilator, and co-administration of other drugs affecting blood pressure may result in pharmacodynamic interactions. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • वैल्प्रोइक एसिडएंटीकन्वल्सेंट (दौरे की दवा)मध्यम

    Valproic acid may increase the exposure to nifedipine during concomitant therapy. (निफेडिपिन लेबल, सावधानियां)

  • वोरिकोनाज़ोलएज़ोल एंटीफंगलमध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • साइक्लोबेंज़ाप्रिनमसल रिलैक्सेंटमध्यम

    …concomitant use of TONMYA with: MAO inhibitors may be life-threatening [see Contraindications (4) ] , Alcohol, barbiturates, and other CNS depressants may increase the risk of adverse reactions associated with these drugs, Tramadol may increase the seizure risk, Guanethidine or other similar acting drugs may block the antihypertensive action of these drugs. (साइक्लोबेंज़ाप्रिन लेबल, दवाओं के इंटरैक्शन)

  • Metformin: A single dose metformin-nifedipine interaction study in normal healthy volunteers demonstrated that co-administration of nifedipine increased plasma metformin C max and AUC by 20% and 9%, respectively, and increased the amount of metformin excreted in urine. (निफेडिपिन लेबल, सावधानियां)

  • सिनाकैल्सेटCYP2D6 इनहिबिटरमध्यम

    If corrected serum calcium falls below the lower limit of normal or symptoms of hypocalcemia develop, start or increase calcium supplementation (including calcium, calcium-containing phosphate binders, and/or vitamin D sterols or increases in dialysate calcium concentration). (सिनाकैल्सेट लेबल, चेतावनियां और सावधानियां)

  • सिप्रोफ्लॉक्सासिनफ्लुओरोक्विनोलोनमध्यम

    …polymeric phosphate binders (for example, sevelamer, lanthanum carbonate); sucralfate; Videx ® (didanosine) chewable/buffered tablets or pediatric powder; other highly buffered drugs; or products containing calcium, iron, or zinc and dairy products) Ciprofloxacin should be taken at least two hours before or six hours after Multivalent cation-containing products administration… (सिप्रोफ्लॉक्सासिन लेबल, दवाओं के इंटरैक्शन)

  • सिमवास्टेटिनस्टेटिनमध्यम

    Amiodarone, Dronedarone, Ranolazine, or Calcium Channel Blockers Clinical Impact: The risk of myopathy and rhabdomyolysis is increased by concomitant use of amiodarone, dronedarone, ranolazine, or calcium channel blockers with ZOCOR. (सिमवास्टेटिन लेबल, दवाओं के इंटरैक्शन)

  • सिमेटिडीनH2 ब्लॉकरमध्यम

    Cimetidine: Five studies in healthy volunteers investigated the impact of multiple cimetidine doses on the single or multiple dose pharmacokinetics of nifedipine. (निफेडिपिन लेबल, सावधानियां)

  • सिरोलिमसइम्यूनोसप्रेसेंटमध्यम

    Sirolimus: A single 60 mg dose of nifedipine and a single 10 mg dose of sirolimus oral solution were administered to 24 healthy volunteers. (निफेडिपिन लेबल, सावधानियां)

  • सिलोडोसिनअल्फा ब्लॉकरमध्यम

    Central Alpha1-Blockers Doxazosin: Healthy volunteers participating in a multiple dose doxazosin-nifedipine interaction study received 2 mg doxazosin q.d. alone or combined with 20 mg nifedipine ER b.i.d. Co-administration of nifedipine resulted in a decrease in AUC and C max of doxazosin to 83% and 86% of the values in the absence of nifedipine, respectively. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • सिल्डेनाफिलPDE5 इनहिबिटरमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • Initiate and/or adjust antihypertensive therapy as appropriate. (सुनिटिनिब लेबल, चेतावनियां और सावधानियां)

  • Monitor patients to assure diuretic efficacy including antihypertensive effects. (सुमाट्रिप्टान और नेप्रोक्सेन लेबल, दवाओं के इंटरैक्शन)

  • सुवोरेक्सेंटसेडेटिव-हिप्नोटिक (नींद की दवा)मध्यम

    …as ketoconazole, fluconazole, itraconazole, clarithromycin, erythromycin (Azithromycin, although structurally related to the class of macrolide antibiotic is void of clinically relevant CYP3A4 inhibition), grapefruit, nefazodone, fluoxetine, saquinavir, indinavir, nelfinavir, and ritonavir may result in increased exposure to nifedipine when co-administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • Intervention: During concomitant use of VYSCOXA with diuretics, observe patients for signs of worsening renal function, in addition to assuring diuretic efficacy including antihypertensive effects [ see Warnings and Precautions (5.6) ]. (सेलेकॉक्सिब लेबल, दवाओं के इंटरैक्शन)

  • सेवोफ्लुरेनजनरल एनेस्थेटिकमध्यम

    Calcium antagonists Sevoflurane may lead to marked hypotension in patients treated with calcium antagonists. (सेवोफ्लुरेन लेबल, दवाओं के इंटरैक्शन)

  • Metformin: A single dose metformin-nifedipine interaction study in normal healthy volunteers demonstrated that co-administration of nifedipine increased plasma metformin C max and AUC by 20% and 9%, respectively, and increased the amount of metformin excreted in urine. (निफेडिपिन लेबल, सावधानियां)

  • सोटालोलबीटा ब्लॉकरमध्यम

    These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment, and may be more likely in patients using concomitant beta-blockers. (निफेडिपिन लेबल, चेतावनियां)

  • Consider temporary or permanent discontinuation for severe or persistent hypertension despite antihypertensive therapy. (सोराफेनिब लेबल, चेतावनियां और सावधानियां)

  • स्पिरोनोलैक्टोनएल्डोस्टेरोन एंटागोनिस्टमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • स्पिरोनोलैक्टोन और हाइड्रोक्लोरोथायज़ाइडएल्डोस्टेरोन एंटागोनिस्टमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • हाइड्रालाज़िनवैसोडाइलेटरमध्यम

    Nifedipine is a vasodilator, and co-administration of other drugs affecting blood pressure may result in pharmacodynamic interactions. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • हाइड्रोकोडोनओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • हाइड्रोक्लोरोथायज़ाइडथायज़ाइड डाइयूरेटिकमध्यम

    Other Diuretics, PDE5 inhibitors, alpha-methyldopa: Nifedipine may increase the blood pressure lowering effect of these concomitantly administered agents. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • हाइड्रोमॉर्फोनओपिओइडमध्यम

    The interaction with high-dose fentanyl appears to be due to the combination of nifedipine and a beta-blocker, but the possibility that it may occur with nifedipine alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out. (निफेडिपिन लेबल, चेतावनियां)

  • हेपरिनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    Antithrombotics Coumarins: There have been rare reports of increased prothrombin time in patients taking coumarin anticoagulants to whom nifedipine was administered. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

मामूली ज़िक्र (94)

  • इंसुलिन एस्पार्टइंसुलिनमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • इंसुलिन ग्लार्जिनइंसुलिनमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • इंसुलिन डेग्लुडेकइंसुलिनमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • इंसुलिन डेटेमिरइंसुलिनमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • इंसुलिन लिस्प्रोइंसुलिनमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • इकाटिबेंटमामूली

    ACE Inhibitors FIRAZYR is a bradykinin B2 receptor antagonist and thereby has the potential to have a pharmacodynamic interaction with ACE inhibitors where FIRAZYR may attenuate the antihypertensive effect of ACE inhibitors. (इकाटिबेंट लेबल, दवाओं के इंटरैक्शन)

  • इन्फ्लिक्सिमैबइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • इब्यूटिलाइडएंटीएरिदमिकमामूली

    Cardiovascular Drugs Antiarrhythmics Quinidine: Quinidine is a substrate of CYP3A and has been shown to inhibit CYP3A in vitro . (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • इर्बेसार्टनएंजियोटेंसिन II रिसेप्टर ब्लॉकर (ARB)मामूली

    Angiotensin-II Blockers Irbesartan: In vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites by nifedipine. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • इसराडिपिनडाइहाइड्रोपाइरिडीन कैल्शियम चैनल ब्लॉकरमामूली

    In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. (इसराडिपिन लेबल, दवाओं के इंटरैक्शन)

  • उपाडासिटिनिबइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • उस्टेकिनुमैबइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • एक्सेनाटाइडGLP-1 रिसेप्टर एगोनिस्टमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • एज़ाथियोप्रिनइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • एटैनरसेप्टइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • एटोडोलैकNSAIDमामूली

    Drug Interactions ACE-inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. (एटोडोलैक लेबल, दवाओं के इंटरैक्शन)

  • एडालिमुमैबइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • एडेनोसिनएंटीएरिदमिकमामूली

    Cardiovascular Drugs Antiarrhythmics Quinidine: Quinidine is a substrate of CYP3A and has been shown to inhibit CYP3A in vitro . (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एफेड्रिनसिम्पैथोमिमेटिकमामूली

    Examples: α-adrenergic antagonists, β-adrenergic receptor antagonists, reserpine, quinidine, mephentermine Other Drug Interactions G u anethidine C linical Impact: Ephedrine may inhibit the neuron blockage produced by guanethidine, resulting in loss of antihypertensive effectiveness. (एफेड्रिन लेबल, दवाओं के इंटरैक्शन)

  • एबाटासेप्टइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • एब्रोसिटिनिबJAK इनहिबिटरमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • एमिकासिनएमिनोग्लाइकोसाइडमामूली

    If neuromuscular blockade occurs, it may be reversed by the administration of calcium salts but mechanical respiratory assistance may be necessary. (एमिकासिन लेबल, चेतावनियां और सावधानियां)

  • एम्पाग्लिफ्लोज़िनSGLT2 इनहिबिटरमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • एलेंड्रोनेटबिस्फॉस्फोनेटमामूली

    Calcium supplements, antacids or oral medications containing multivalent cations interfere with absorption of alendronate. (एलेंड्रोनेट लेबल, दवाओं के इंटरैक्शन)

  • एलेमटुज़ुमैबइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • एलोग्लिप्टिनDPP-4 इनहिबिटरमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • ओक्रेलिज़ुमैबइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • कीटोप्रोफेनNSAIDमामूली

    ACE-inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. (कीटोप्रोफेन लेबल, चेतावनियां और सावधानियां)

  • कीटोरोलैकNSAIDमामूली

    Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors and/or angiotensin II receptor antagonists. (कीटोरोलैक लेबल, दवाओं के इंटरैक्शन)

  • कैंडेसार्टनएंजियोटेंसिन II रिसेप्टर ब्लॉकर (ARB)मामूली

    Candesartan: No significant drug interaction has been reported in studies with candesartan cilexitil given together with nifedipine. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • कैनाग्लिफ्लोज़िनSGLT2 इनहिबिटरमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • कैबोटेग्राविरएंटीरेट्रोवायरलमामूली

    Concomitant Drug Class: Drug Name Effect on Concentration Clinical Comment Antacids containing polyvalent cations (e.g., aluminum or magnesium hydroxide, calcium carbonate) ↓Cabotegravir Administer antacid products at least 2 hours before or 4 hours after taking VOCABRIA. (कैबोटेग्राविर लेबल, दवाओं के इंटरैक्शन)

  • क्लोरप्रोमाज़िनएंटीसाइकोटिकमामूली

    Chlorpromazine may counteract the antihypertensive effect of guanethidine and related compounds. (क्लोरप्रोमाज़िन लेबल, चेतावनियां)

  • गुसेलकुमैबइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • ग्लिपिज़ाइडसल्फोनिलयूरियामामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • ग्लिबेनक्लामाइडसल्फोनिलयूरियामामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • ग्लिमेपिराइडसल्फोनिलयूरियामामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • ज़ाफिरलुकास्टल्यूकोट्राइन रिसेप्टर एंटागोनिस्टमामूली

    No other formal drug-drug interaction studies between zafirlukast and marketed drugs known to be metabolized by the P450 3A4 (CYP3A4) isoenzyme (e.g., dihydropyridine calcium-channel blockers, cyclosporin, cisapride) have been conducted. (ज़ाफिरलुकास्ट लेबल, सावधानियां)

  • जेंटामाइसिनएमिनोग्लाइकोसाइडमामूली

    If neuromuscular blockade occurs, calcium salts may reverse it. (जेंटामाइसिन लेबल, दवाओं के इंटरैक्शन)

  • टर्बिनाफिनएंटीफंगलमामूली

    There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, phenytoins, thiazide diuretics, and calcium channel blockers. (टर्बिनाफिन लेबल, दवाओं के इंटरैक्शन)

  • टिर्ज़ेपाटाइडGLP-1 रिसेप्टर एगोनिस्टमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • टेरिफ्लुनोमाइडइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • टोफासिटिनिबइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • टोल्मेटिनNSAIDमामूली

    DRUG INTERACTIONS ACE Inhibitors: Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE Inhibitors. (टोल्मेटिन लेबल, दवाओं के इंटरैक्शन)

  • टोसिलिज़ुमैबइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • ट्राइफ्लुओपेराज़िनएंटीसाइकोटिकमामूली

    Antihypertensive effects of guanethidine and related compounds may be counteracted when phenothiazines are used concurrently. (ट्राइफ्लुओपेराज़िन लेबल, सावधानियां)

  • Drug Interactions ACE-inhibitors and Angiotensin II Anagonists Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors and angiotensin II antagonists. (डाइफ्लुनिसाल लेबल, दवाओं के इंटरैक्शन)

  • डाइमिथाइल फ्यूमरेटइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • डाइसोपाइरामाइडएंटीएरिदमिकमामूली

    Cardiovascular Drugs Antiarrhythmics Quinidine: Quinidine is a substrate of CYP3A and has been shown to inhibit CYP3A in vitro . (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • डुलाग्लूटाइडGLP-1 रिसेप्टर एगोनिस्टमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • डेक्सट्रोएम्फेटामाइनCNS स्टिमुलेंटमामूली

    Antihypertensives Amphetamines may antagonize the hypotensive effects of antihypertensives. (डेक्सट्रोएम्फेटामाइन लेबल, दवाओं के इंटरैक्शन)

  • डेसफ्लुरेनजनरल एनेस्थेटिकमामूली

    …malignant hyperthermia in patients with known or suspected susceptibility based on genetic factors or family history, including those with certain inherited ryanodine receptor (RYR1) or dihydropyridine receptor (CACNA1S) variants. [see Contraindications (4), Clinical Pharmacology (12.5)] Signs consistent with malignant hyperthermia may include hyperthermia, hypoxia,… (डेसफ्लुरेन लेबल, चेतावनियां और सावधानियां)

  • डेसिप्रामिनट्राइसाइक्लिक एंटीडिप्रेसेंटमामूली

    This drug is capable of blocking the antihypertensive effect of guanethidine and similarly acting compounds. (डेसिप्रामिन लेबल, चेतावनियां)

  • If other contraceptive methods are not suitable, hormonal contraceptive therapy may continue combined with antihypertensive therapy. (डेसोजेस्ट्रेल और एथिनिल एस्ट्राडियोल लेबल, चेतावनियां)

  • डैपाग्लिफ्लोज़िनSGLT2 इनहिबिटरमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • निसोल्डिपिनडाइहाइड्रोपाइरिडीन कैल्शियम चैनल ब्लॉकरमामूली

    The blood pressure effect of SULAR tended to be greater in patients on atenolol than in patients on no other antihypertensive therapy. (निसोल्डिपिन लेबल, दवाओं के इंटरैक्शन)

  • नेटेग्लिनाइडमेग्लिटिनाइडमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • नैटालिज़ुमैबइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • नैबुमेटोनNSAIDमामूली

    Drug Interactions: ACE-inhibitors: Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. (नैबुमेटोन लेबल, दवाओं के इंटरैक्शन)

  • नॉरट्रिप्टिलीनट्राइसाइक्लिक एंटीडिप्रेसेंटमामूली

    The antihypertensive action of guanethidine and similar agents may be blocked. (नॉरट्रिप्टिलीन लेबल, चेतावनियां)

  • पिमेक्रोलिमसकैल्सिन्यूरिन इनहिबिटरमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • पियोग्लिटाज़ोनथायज़ोलिडिनडायोनमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • पियोग्लिटाज़ोन और ग्लिमेपिराइडथायज़ोलिडिनडायोनमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • पैंटोप्राज़ोलप्रोटॉन पंप इनहिबिटरमामूली

    Pantoprazole: In healthy volunteers the exposure to neither drug was changed significantly in the presence of the other drug. (निफेडिपिन लेबल, सावधानियां)

  • प्रोकेनामाइडएंटीएरिदमिकमामूली

    Cardiovascular Drugs Antiarrhythmics Quinidine: Quinidine is a substrate of CYP3A and has been shown to inhibit CYP3A in vitro . (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • प्रोक्लोरपेराज़िनएंटीसाइकोटिकमामूली

    Antihypertensive effects of guanethidine and related compounds may be counteracted when phenothiazines are used concomitantly. (प्रोक्लोरपेराज़िन लेबल, सावधानियां)

  • प्रोट्रिप्टिलीनट्राइसाइक्लिक एंटीडिप्रेसेंटमामूली

    Protriptyline may block the antihypertensive effect of guanethidine or similarly acting compounds. (प्रोट्रिप्टिलीन लेबल, चेतावनियां)

  • प्रोपाफेनोनएंटीएरिदमिकमामूली

    Cardiovascular Drugs Antiarrhythmics Quinidine: Quinidine is a substrate of CYP3A and has been shown to inhibit CYP3A in vitro . (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • फिंगोलिमोडइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • फिनास्टेराइड5-अल्फा रिडक्टेज़ इनहिबिटरमामूली

    …studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H 2 antagonists and quinolone anti-infectives… (फिनास्टेराइड लेबल, दवाओं के इंटरैक्शन)

  • फ्लेकेनाइडएंटीएरिदमिकमामूली

    Flecainide: There has been too little experience with the co-administration of Tambocor with nifedipine to recommend concomitant use. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • बेक्साग्लिफ्लोज़िनSGLT2 इनहिबिटरमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • बैरिसिटिनिबJAK इनहिबिटरमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • मर्कैप्टोप्यूरिनएंटीमेटाबोलाइटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • माइकोफेनोलेटइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • मिग्लिटोलएंटीडायबिटिक (डायबिटीज़ की दवा)मामूली

    Miglitol: No effect of miglitol was observed on the pharmacokinetics and pharmacodynamics of nifedipine. (निफेडिपिन लेबल, सावधानियां)

  • मेक्सिलेटिनएंटीएरिदमिकमामूली

    Cardiovascular Drugs Antiarrhythmics Quinidine: Quinidine is a substrate of CYP3A and has been shown to inhibit CYP3A in vitro . (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • मेथोट्रेक्सेटइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • रिटलेसिटिनिबJAK इनहिबिटरमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • रिटुक्सिमैबइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • लिडोकेनलोकल एनेस्थेटिकमामूली

    Cardiovascular Drugs Antiarrhythmics Quinidine: Quinidine is a substrate of CYP3A and has been shown to inhibit CYP3A in vitro . (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • लिडोकेन और प्रिलोकेनलोकल एनेस्थेटिकमामूली

    Cardiovascular Drugs Antiarrhythmics Quinidine: Quinidine is a substrate of CYP3A and has been shown to inhibit CYP3A in vitro . (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • लिनाग्लिप्टिनDPP-4 इनहिबिटरमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • लिराग्लूटाइडGLP-1 रिसेप्टर एगोनिस्टमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • लेफ्लुनोमाइडइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • सक्सिनिलकोलिनन्यूरोमस्कुलर ब्लॉकरमामूली

    QUELICIN can induce malignant hyperthermia in patients with known or suspected susceptibility based on genetic factors or family history, including those with certain inherited ryanodine receptor (RYR1) or dihydropyridine receptor (CACNA1S) variants. [see Contraindications (4) , Clinical Pharmacology (12.5) ] . (सक्सिनिलकोलिन लेबल, चेतावनियां और सावधानियां)

  • साइक्लोफॉस्फामाइडइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • साल्सालेटNSAIDमामूली

    DRUG INTERACTIONS ACE-inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. (साल्सालेट लेबल, दवाओं के इंटरैक्शन)

  • सिटाग्लिप्टिनDPP-4 इनहिबिटरमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • सुलिंडैकNSAIDमामूली

    Drug Interactions ACE-Inhibitors and Angiotensin II Antagonists Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors and angiotensin II antagonists. (सुलिंडैक लेबल, दवाओं के इंटरैक्शन)

  • सेक्यूकिनुमैबइम्यूनोसप्रेसेंटमामूली

    Immunosuppressive Drugs Tacrolimus: Tacrolimus has been shown to be metabolized via the CYP3A system. (निफेडिपिन लेबल, सावधानियां)

  • सेमाग्लूटाइडGLP-1 रिसेप्टर एगोनिस्टमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

  • सैक्साग्लिप्टिनDPP-4 इनहिबिटरमामूली

    Glucose Lowering Drugs Pioglitazone: Co-administration of pioglitazone for 7 days with 30 mg nifedipine ER administered orally q.d. for 4 days to male and female volunteers resulted in least square mean (90% CI) values for unchanged nifedipine of 0.83 (0.73-0.95) for C max and 0.88 (0.80-0.96) for AUC relative to nifedipine monotherapy. (निफेडिपिन लेबल, सावधानियां)

कोई महत्वपूर्ण इंटरैक्शन नहीं बताया गया (16)

  • एमिनोफाइलिनमिथाइलज़ैंथिनकोई इंटरैक्शन नहीं

    …finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption)… (एमिनोफाइलिन लेबल, दवाओं के इंटरैक्शन)

  • एस्पिरिनNSAIDकोई इंटरैक्शन नहीं

    Platelet Aggregation Inhibitors Clopidogrel: No clinically significant pharmacodynamic interactions were observed when clopidogrel was co-administered with nifedipine. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • एस्पिरिन और डाइपिरिडामोलएंटीप्लेटलेट दवाकोई इंटरैक्शन नहीं

    Platelet Aggregation Inhibitors Clopidogrel: No clinically significant pharmacodynamic interactions were observed when clopidogrel was co-administered with nifedipine. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ऑर्फेनाड्रिन, एस्पिरिन और कैफीनमसल रिलैक्सेंटकोई इंटरैक्शन नहीं

    Platelet Aggregation Inhibitors Clopidogrel: No clinically significant pharmacodynamic interactions were observed when clopidogrel was co-administered with nifedipine. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ऑर्लिस्टैटकोई इंटरैक्शन नहीं

    Drugs Interfering with Food Absorption Orlistat: In 17 normal-weight subjects receiving orlistat 120 mg t.i.d. for 6 days, orlistat did not alter the bioavailability of 60 mg nifedipine (extended-release tablets). (निफेडिपिन लेबल, सावधानियां)

  • ओसेल्टामिविरएंटीवायरलकोई इंटरैक्शन नहीं

    …Clinically Significant Drug Interaction with TAMIFLU No dose adjustments are needed for either oseltamivir or the concomitant drug when coadministering oseltamivir with amoxicillin, acetaminophen, aspirin, cimetidine, antacids (magnesium and aluminum hydroxides and calcium carbonates), rimantadine, amantadine, or warfarin [see Clinical Pharmacology (12.3) ] . (ओसेल्टामिविर लेबल, दवाओं के इंटरैक्शन)

  • कैंग्रेलोरएंटीप्लेटलेट दवाकोई इंटरैक्शन नहीं

    Platelet Aggregation Inhibitors Clopidogrel: No clinically significant pharmacodynamic interactions were observed when clopidogrel was co-administered with nifedipine. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • क्लोपिडोग्रेलएंटीप्लेटलेट दवाकोई इंटरैक्शन नहीं

    Platelet Aggregation Inhibitors Clopidogrel: No clinically significant pharmacodynamic interactions were observed when clopidogrel was co-administered with nifedipine. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • टिरोफिबैनएंटीप्लेटलेट दवाकोई इंटरैक्शन नहीं

    Tirofiban: Co-administration of nifedipine did not alter the exposure to tirofiban importantly. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • डाइपिरिडामोलएंटीप्लेटलेट दवाकोई इंटरैक्शन नहीं

    Platelet Aggregation Inhibitors Clopidogrel: No clinically significant pharmacodynamic interactions were observed when clopidogrel was co-administered with nifedipine. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • थियोफाइलिनमिथाइलज़ैंथिनकोई इंटरैक्शन नहीं

    …mebendazole amoxicillin medroxyprogesterone ampicillin, with or without methylprednisolone sulbactam metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine… (थियोफाइलिन लेबल, दवाओं के इंटरैक्शन)

  • प्रासुग्रेलएंटीप्लेटलेट दवाकोई इंटरैक्शन नहीं

    Platelet Aggregation Inhibitors Clopidogrel: No clinically significant pharmacodynamic interactions were observed when clopidogrel was co-administered with nifedipine. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • ब्यूटाल्बिटल, एस्पिरिन और कैफीनबार्बिट्यूरेटकोई इंटरैक्शन नहीं

    Platelet Aggregation Inhibitors Clopidogrel: No clinically significant pharmacodynamic interactions were observed when clopidogrel was co-administered with nifedipine. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

  • मिडाज़ोलमबेंज़ोडायज़ेपिनकोई इंटरैक्शन नहीं

    No interaction was observed in healthy subjects between midazolam and nifedipine. (मिडाज़ोलम लेबल, दवाओं के इंटरैक्शन)

  • राल्टेग्राविरएंटीरेट्रोवायरलकोई इंटरैक्शन नहीं

    Moreover, atazanavir, atazanavir/ritonavir, boceprevir, calcium carbonate antacids, darunavir/ritonavir, efavirenz, etravirine, omeprazole, or tipranavir/ritonavir did not have a clinically meaningful effect on the pharmacokinetics of raltegravir. (राल्टेग्राविर लेबल, दवाओं के इंटरैक्शन)

  • सिलोस्टाज़ोलएंटीप्लेटलेट दवाकोई इंटरैक्शन नहीं

    Platelet Aggregation Inhibitors Clopidogrel: No clinically significant pharmacodynamic interactions were observed when clopidogrel was co-administered with nifedipine. (निफेडिपिन लेबल, दवाओं के इंटरैक्शन)

आप जो कुछ भी लेते हैं, उस सबके साथ निफेडिपिन को जांचें। अपनी पूरी सूची जोड़ें; हर जोड़ी एक साथ जांची जाती है।

चेकर में खोलें

यह चिकित्सकीय सलाह नहीं है। गंभीरता लेबल के शब्दों को दर्शाती है, आपकी परिस्थितियों को नहीं। “गंभीर” चिह्न वाला संयोजन डॉक्टर की देखरेख में सामान्य बात हो सकता है, और “मामूली” चिह्न वाला संयोजन ऊंची खुराक पर मायने रख सकता है। फार्मासिस्ट से पूछें।